Literature DB >> 33452387

Vulnerability to shear stress caused by altered peri-endothelial matrix is a key feature of Moyamoya disease.

Muneaki Matsuo1, Satomi Nadanaka2, Minami Soga3, Taku Sugiyama4, Shota Serigano5, Kenjiro Shimano5, Fumio Ichinose6, Takuji Nakamura6, Toshiyuki Maeda6, Kiyohiro Houkin4, Takumi Era3, Hiroshi Kitagawa2.   

Abstract

Moyamoya disease (MMD) is characterized by progressive bilateral stenotic changes in the terminal portion of the internal carotid arteries. Although RNF213 was identified as a susceptibility gene for MMD, the exact pathogenesis remains unknown. Immunohistochemical analysis of autopsy specimens from a patient with MMD revealed marked accumulation of hyaluronan and chondroitin sulfate (CS) in the thickened intima of occlusive lesions of MMD. Hyaluronan synthase 2 was strongly expressed in endothelial progenitor cells in the thickened intima. Furthermore, MMD lesions showed minimal staining for CS and hyaluronan in the endothelium, in contrast to control endothelium showing positive staining for both. Glycosaminoglycans of endothelial cells derived from MMD and control induced pluripotent stem cells demonstrated a decreased amount of CS, especially sulfated CS, in MMD. A computational fluid dynamics model showed highest wall shear stress values in the terminal portion of the internal carotid artery, which is the predisposing region in MMD. Because the peri-endothelial extracellular matrix plays an important role in protection, cell adhesion and migration, an altered peri-endothelial matrix in MMD may contribute to endothelial vulnerability to wall shear stress. Invading endothelial progenitor cells repairing endothelial injury would produce excessive hyaluronan and CS in the intima, and cause vascular stenosis.

Entities:  

Year:  2021        PMID: 33452387      PMCID: PMC7810726          DOI: 10.1038/s41598-021-81282-9

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  25 in total

Review 1.  Insight into the role of chondroitin sulfate E in angiogenesis.

Authors:  Pinelopi Kastana; Effrosyni Choleva; Evangelia Poimenidi; Nikos Karamanos; Kazuyuki Sugahara; Evangelia Papadimitriou
Journal:  FEBS J       Date:  2019-04-10       Impact factor: 5.542

Review 2.  Moyamoya disease: current concepts and future perspectives.

Authors:  Satoshi Kuroda; Kiyohiro Houkin
Journal:  Lancet Neurol       Date:  2008-11       Impact factor: 44.182

3.  When and why is surgical revascularization indicated for the treatment of moyamoya syndrome in patients with RASopathies? A systematic review of the literature and a single institute experience.

Authors:  Marcello Scala; Pietro Fiaschi; Valeria Capra; Maria Luisa Garrè; Domenico Tortora; Marcello Ravegnani; Marco Pavanello
Journal:  Childs Nerv Syst       Date:  2018-05-24       Impact factor: 1.475

4.  Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain.

Authors:  J Suzuki; A Takaku
Journal:  Arch Neurol       Date:  1969-03

5.  Costello syndrome showing moyamoya-like vasculopathy.

Authors:  Takashi Shiihara; Mitsuhiro Kato; Yoshihiko Mitsuhashi; Kiyoshi Hayasaka
Journal:  Pediatr Neurol       Date:  2005-05       Impact factor: 3.372

6.  Bone marrow-derived endothelial progenitor cells participate in the initiation of moyamoya disease.

Authors:  Taku Sugiyama; Satoshi Kuroda; Naoki Nakayama; Shinya Tanaka; Kiyohiro Houkin
Journal:  Neurol Med Chir (Tokyo)       Date:  2011       Impact factor: 1.742

7.  Increased levels of circulating SDF-1α and CD34+ CXCR4+ cells in patients with moyamoya disease.

Authors:  G Ni; W Liu; X Huang; S Zhu; X Yue; Z Chen; M Chen; X Liu; G Xu
Journal:  Eur J Neurol       Date:  2011-03-24       Impact factor: 6.089

8.  Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus.

Authors:  Utako Yokoyama; Susumu Minamisawa; Hong Quan; Shibnath Ghatak; Toru Akaike; Eri Segi-Nishida; Shiho Iwasaki; Mari Iwamoto; Suniti Misra; Kouichi Tamura; Hideaki Hori; Shumpei Yokota; Bryan P Toole; Yukihiko Sugimoto; Yoshihiro Ishikawa
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

Review 9.  Glycoconjugates and related molecules in human vascular endothelial cells.

Authors:  Norihiko Sasaki; Masashi Toyoda
Journal:  Int J Vasc Med       Date:  2013-09-19

10.  New insights into the pathobiology of Down syndrome--hyaluronan synthase-2 overexpression is regulated by collagen VI α2 chain.

Authors:  Evgenia Karousou; Xanthi Stachtea; Paola Moretto; Manuela Viola; Davide Vigetti; Maria Luisa D'Angelo; Luigi Raio; Fabio Ghezzi; Francesco Pallotti; Giancarlo De Luca; Nikos K Karamanos; Alberto Passi
Journal:  FEBS J       Date:  2013-03-28       Impact factor: 5.542

View more
  3 in total

Review 1.  Novel Multifaceted Roles for RNF213 Protein.

Authors:  Giuliana Pollaci; Gemma Gorla; Antonella Potenza; Tatiana Carrozzini; Isabella Canavero; Anna Bersano; Laura Gatti
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

2.  Transcriptomic Profiling of Intracranial Arteries in Adult Patients With Moyamoya Disease Reveals Novel Insights Into Its Pathogenesis.

Authors:  Shuangxiang Xu; Wei Wei; Feiyang Zhang; Tongyu Chen; Lixin Dong; Jichun Shi; Xiaolin Wu; Tingbao Zhang; Zhengwei Li; Jianjian Zhang; Xiang Li; Jincao Chen
Journal:  Front Mol Neurosci       Date:  2022-05-31       Impact factor: 6.261

3.  Long-Lasting Unruptured Large Intracranial Aneurysm in Bilateral Moyamoya Disease: Case Report.

Authors:  Eunyoung Chae; Soomin Jeong; Chan-Hyuk Lee
Journal:  Case Rep Neurol Med       Date:  2022-09-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.